Streptobacillus moniliformis (Sm), the causative agent of rat-bite fever and Haverhill fever in man, is also a pathogen in certain laboratory and domestic animals. With the introduction of modern maintenance systems, this microorganism seemed to be eradicated from laboratory animal units, but recent reports of Streptobacillus moniliformis (Sm) in colonies of laboratory rodents give evidence that this 'forgotten' bacterium can still be found even behind hygienic barrier systems.
Streptobacillus moniliformis (Sm j is a Gram-negative, non-motile rod which tends to be highly pleomorphic. Depending on the mode of cultivation and the age of the culture, single rods occasionally with lateral bulbar swellings, filaments and chains of variable morphology may be observed (Fig 1) . In serum-supplemented liquid media, bacterial growth shows a typical 'cotton-ball like' appearance. Cultivation of the fermentative 'Present address: Dynamis Zentmm, Steinweg 1, D-30989 Gehrden, Gennany Accepted 5 May 1994 microorganism requires media containing blood, serum or ascites fluid; optimum temperature is 35-37°C. Sm grows optimally under microaerophilic conditions, but also anaerobically and aerobically. It exists in 2 variant types, the 'normal' bacillary form and the inducible or spontaneously occurring L-form which exhibits the typical 'fried-egg' colony morphology. The latter is regarded as an apathogenic Sm variant (Freundt 1956bj . Key reactions which separate Sm from other biochemically related bacteria are catalase, oxidase, indole production and reduction of nitrate to nitrite (Savage 1984) . In all four tests Sm gives negative reactions. Phenotypic characterization of 13 Sm isolates derived from man, turkey, rat and mouse performed with classical biochemical tests (24 carbohydrates, 19 enzymic reactions) and a commercial enzyme test system (apiZYMTM, Niirtingen, FRG) reveals a high degree of conformity. The only variable characters are acid production from salicin, aesculin hydrolysis and activity of trypsin, chymotrypsin and B-glucoronidase (Hofmann & Wullenweber unpublished datal. Recently, the first haemolytic Sm strain isolated from a rat with otitis media was described (Wullenweber et a1. 1992) . This is now available from the American Type Culture Collection as ATCC 49940. Gas-liquid chromatography analysis of the fatty acid pattern of 7 Streptobacillus moniliformis isolates including the type strain demonstrated palmitic, stearic, oleic and linoleic acid as major components (Edwards & Finch 1986 ). Thus, they confirmed previous findings of Rowbotham (1983) based on 9 Sm strains including the four isolates from the Chelmsford epidemic (Shanson et a1. 1983) .
Another approach was adopted by Costas and Owen (1987) . On the basis of numerical analysis of SDS-PAGEprotein profiles they identified 7 subgroups among 31 Sm cultures representing 22 different strains of human, murine and avian origin isolated in Europe, USA and Australia. As these groups showed a close similarity, Wullenweber they concluded that Sm is a very homologous species.
This assessment is supported by the serological findings of Boot et a1. (in press I who tested 11 different Sm strains of human and murine origin for cross-reactivity in an ELISA.They stated that all Sm strains studied were clearly serologically related. In contrast to Costas and Owen (1987) , they neither described differences between human and murine isolates nor between Haverhill fever and rat-bite fever strains.
Taxonomy of Streptobacillus moniliformis
In Bergey's Manual of Systematic Bacteriology (1984) ,Sm is placed in section 5: 'Facultatively anaerobic Gram-negative rods'. Savage (1984) commented on its taxonomic position: 'It seems desirable not to ally it with any particular family until more definitive taxonomic studies, such as nucleic acid hybridizations, are done.' Although these data are still missing there is some information on the relationship to other procaryotes.
The mol% G + C of the DNA for the Lphase variant of Sm is 24-26, and of the bacillary form 24-25 (Savage 1984 , Williams et al. 1969 . Such low GC values are known only for members of the order Mycoplasmato1es (Razin & Freundt 19841. Pachas et a1. (1986) could show that DNA-DNA hybridization of H3-labelled Acholeplasma laidlawii DNA with the Sm type strain (ATCC 14647, human isolate) gave 21% homology but only 4% with Sm ATCC 27747 (turkey isolate). Later, contradictory results were given by the same group. Thereafter, DNA-DNA hybridization with various A.laidlawii strains gave homology values of only 1.1 to 3.3% (Aulakh et 01. 1987) . Unfortunately, the strains used were not further specified.
The same authors use the immunofluorescence technique to investigate the serological relationship between Sm Lvariants and A. laidlawii. They could not find cross-reactions between antibodies to A. laidlawii and Sm (Pachas et 01. 1986 ). Our own results, obtained using the same technique and of Boot et a1. (in press) using an ELISA, demonstrated a serological relationship between A. laidlawii and the bacillary form of Sm ATCC 49567 and ATCC 14647 (type strain, own unpublished data) respectively strain Sm KUN 3 (Koopman et a1. 1991) . Furthermore, we observed crossreactivity between Sm ATCC 49567 and rabbit antisera against A. axanthum, A. oculi and A. equifeto1e, and no cross-reactivity with antisera to A. granularum, A. modicum, A. hippikon, and A. florum lemon (IIF, own unpublished data. All rabbit antisera against Mycoplasma spp. and Acholeplasma spp. were donated by Prof. Kirchhoff, Veterinary School, Hannover). Moreover, there was no crossreaction between antisera against Mycoplasma arthritidis and M. pulmonis and Sm ATCC 49567 (TIF,own unpublished data).
Thin layer chromatography of acetoneextracted cells showed the lack of quinones in Sm ATCC 14647, ATCC 49567 and ATCC 49940 [Hofmann, unpublished data) which is in agreement with members of the genus Mycoplasma (Razin &. Freundt 1984) . The polyamine patterns of some representative Sm strains are specific and different from those of the alpha-, beta-and gamma-subclass of the proteobacteria (Hofmann unpublished data).
Although Streptobacillus shows more links to some members of the Mycoplasmatales than to other bacteria (Savage 1984) it is still too early to comment further on its phylogenetic origin. Therefore, the question posed by Pachas et 01. (1986) I Streptobacillus moniliformis:
A new parent for Acholeplasma laidlawii?' is still not answered, but it seems worth while to follow this up. Sequencing of the Sm 16S rRNA genes is in progress in the Dept. of Bacteriology (Central Institute, Hannover) with the objective of obtaining reliable information on its genetic relatedness to other bacterial groups. (See Addendum.)
Infectivity spectrum
Humans Sm is a pathogen for humans. Clinical pictures of the disease are similar despite 3 two different modes of transmission. Oral uptake of Sm via contaminated food leads to a disease known as Haverhill fever, named after the place where the first welldocumented epidemic was observed in 1926 (Place &. Sutton 1934) . Affected individuals had consumed unpasteurised milk or milk products to which rats had access. In another well-documented epidemic (Chelmsford, UK 1981) boarding school pupils became affected after using water from a spring in the vicinity of which rats were observed (McEvoy et a1. 1987) . As in Haverhill, Sm was not isolated from captured rats. However, in both cases, epidemiological data suggested it was most probable that foodstuffs or water contaminated by rats were responsible for the epidemics.
Rats are also the source of the second type of human streptobacillosis, the socalled rat-bite fever (RBF). (Another form of rat-bite fever called sodoku is caused by Spirillum minus which is not the subject of this review). Sm can be transmitted by rat-bite, but, recent reports suggest that not only the rat-bite but also simple contact with (pet) rats (Clausen 1987 , Rygg &. Bruun 1992 may result in RBF. The disease is characterized by an acute onset with chills, vomiting, malaise, headache, irregularly relapsing fever, erythematous rash especially of the extremities, and arthralgia. Untreated it often leads to a severe septic polyarthritis and lymphadenopathy. If untreated, mortality is estimated to be about 13% (Roughgarden 1965 , Simon &. Wilson 1986 . Complications of streptobacillary rat-bite fever are endocarditis (Rey et a1. 1987 , Rupp 1992 , pericarditis (Carbeck et a1. 1967) brain abcess (Oeding &. Pedersen 1950) , amnionitis (Faro et a1. 1980 ), septicaemia (Brown &. Nunemaker 1942 , Dellamonica et a1. 1979 , Renaut et a1. 1982 , Rygg &. Bruun 1992 , interstitial pneumonia, prostatitis and pancreatitis (Delannoy et a1. 1991) . Raffin and Freemark (1979) suggest that streptobacillary RBF is a paediatric problem. Roughgarden (1965) found that 55% of reported cases in the United States were children under the age of 12. Infants have died because of an undiagnosed streptobacillosis (McHugh et a1. 1985 , Sens et a1. 1989 , although human streptobacillosis usually has a good prognosis after appropriate antibiotic therapy, e.g. with penicillin. Recent reports describe streptobacillary RBF in a Greek (Konstantopoulos et a1. 1992) and a Norwegian child (Rygg & Bruun 1992) .
Laboratory animals
Information concerning occurrence, pathogenicity, epidemiology etc. of Sm for various laboratory animal species is summarized in Table 1 .
Rat So far as is known, the rat is the natural reservoir of Sm and therefore plays the dominant role in harbouring and transmitting the infectious agent. Most probably the microorganism is a member of the commensal flora of the upper respiratory tract. Hence, main isolation sites in healthy rats are the nasopharynx (Strangeways 1933 (Strangeways ), larynx, upper trachea (peagle et a1. 1976 ) and the middle ear (Koopman et a1. 1991) . Although of only low pathogenicity for the rat, Sm may act as a secondary invader (Weisbroth 1979) in conjunction with presumptive pathogens, such as Pasteurella pneumotropica, Mycoplasma pu1monis or other PPLO causing otitis media (Olson & McCune 1968 , Wullenweber et a1. 1992 in pressl, conjunctivitis (Young & Hill 1974 ), bronchopneumonia (Bell & Elmes 1969 and chronic pneumonia (Gay et a1. 1972) .
Mouse
It is well-documented that laboratory mice may suffer from streptobacillosis. A typical sign of disease is a septic lymphadenitis predominantly of the ventral cervical lymph nodes. Subcutaneous lymph nodes (inguinal and axillary) can also be involved in the final phase of disease whereas septic processes in the mesenteric lymph nodes are rarely observed (Fig 2) . If the mouse survives the acute stage of infection without dying of septicaemia, septic arthritis or polyarthritis (Fig 3) may develop. In addition to the extremities, the tail joints and the spinal cord may be Wullenweber affected. The spleen is usually enlarged and can be patterned by multiple micro-abscesses (Kaspareit-Rittinghausen et a1. 1990; Wullenweber et a1. 1990 ). Abscesses of the liver and ovary, pericarditis and purulent keratoconjunctivitis are limited to individual cases (Nagel 1991) . Septicaemia is often accompanied by cachexia and is usually fatal. Sawicki et a1. (1962) found that Sm caused abortion in pregnant mice.
We studied the course of infection after oral administration of Sm ATCC 49567 which was isolated during a devastating epizootic among C57BL/6 mice in our institute in 1988 (Wullenweber et a1. 1990) . At 3 days post infection (dpi) lentilsized abscessation in the submaxillary lymph nodes were observed at necropsy. About 7 dpi abscessation of the ventral neck became macroscopically visible as swellings in the intact mice. Abscesses were already bean-sized (about 1 cml. If untreated, the mice died from septicaemia usually within further 3 to 5 days. Sm could then be isolated from the affected lymph nodes, blood and spleen.
Injection of Sm into the tail vein leads to a septic polyarthritis of the hind legs without involvement of the lymph nodes and may lead to a spontaneous amputation of the affected extremity (Freundt 1956a) .
Sm may cause epizootic infections in stocks of micej 4 are documented (Mackie et a1. 1933 , Freundt 1956a , Sawicki 1962 , Wullenweber et a1. 1990 In one (Freundt 1956a ) the epizootic could be traced back to contaminated rats as the source of infection whereas in the other cases (Mackie et a1. 1933 , Wullenweber et a1. 1990 ) the origin of Sm remained obscure or was not given (Sawicki et a1. 1962) .
Besides animal welfare considerations and the health risk to personnel, such an epizootic results in severe economic and scientific loss, as entry of Sm into a laboratory animal unit always requires the subsequent close-down of the entire unit.
On the occasion of the Hannover epizootic, we observed that only C57BL! 6 mice showed clinical signs of streptobacillosisj other inbred and athymic strains of mice remained healthy, and therefore, we assume Guineapig Granulomatous pneumonia TypicalSm Kirchner et al. 1992 Gerbil b Healthy Caused human infection Wilkens et al. 1988 'only the report's title is available bnot from a laboratory animal breeder 5 that the genetic background of the host must influence the outcome of infection. Mackie et al. (1933) and Van Rooyen (1936) referring to the same epizootic, observed differences in susceptibility to disease in two different strains of mice. Levaditi et al. (1932) observed differences in susceptibility to streptobacillosis between their laboratory strain of white mice and wild mice after experimental infection. Therefore a study was undertaken to elucidate the influence of the genetic background on the course of disease IWullenweber et al. 1991). This is now complete (Wullenweber et al. in preparation) . Briefly, one can state that out of a broad panel of inbred strains of mice, only C57BL/6 mice develop the typical signs of streptobacillosis. AKR/N mice show a short period of mild illness post infection, but recover completely. In contrast to other strains, C57BL/6 and AKR/N mice exhibit a strong antibody response. MHC-genes and the ability to produce functional T-and/or B-cells do not influence the development of disease.
As genetic host factors are involved in the disease process, it is most probable that within a population of outbred mice, one will find susceptible and resistant animals. This might explain why experimental infection of outbred mice, especially if only small numbers are used, may fail, as was observed in recent reports (Rygg &. Bruun 1992, Boot et al. in press) . To circumvent these problems, the use of C57BL/6 or C57BL/10 mice as sentinel animals for streptobacillosis is recommended.
With respect to the health risk for laboratory personnel and animal caretakers, it is important to know whether laboratory mice can function as clinically silent carriers of Sm. Savage et al. (1981) observed that Sm persisted for about 6 months.in infected animals. In contrast to Levaditi et al. (1932) , neither Freundt (1956a) nor Wullenweber et al. (1990) could ever isolate Sm from urine and caecal contents. However, orally infected, diseased C57BL/6 mice harboured Sm up to 24 dpi in their nasopharynx, but BALB/c (which are resistant to streptobacillosis) were negative from 3 dpi until the end of the study at 60 dpi (Nagel 1991) . During the Hannover epizootic, we screened about 200 nasopharyngeal swabs from mouse strains, other than C57BL/6, from the same unit for Sm. All attempts to isolate Sm failed. From these observations, it seems that there is a low risk of the bite of an inbred mouse, other than a Sm-infected C57BL/6, transmitting RBF. However, the situation may be different if outbred strains of mice or wild mice are used (see also below, occupational risk).
Guineapig There are 4 reports of disease caused by Sm in guineapigs (Smith 1941 , Aldred et al. 1974 , Fleming 1976 , Kirchner et al. 1992 . Kirchner et al. (1992) described a case of granulomatous pneumonia. The isolate showed the typical morphological and biochemical characters of Sm, and its facultative anaerobiosis. The other reports on Sm isolated from guineapigs described an obligate anaerobiont unable to ferment carbohydrates which is unusual for Sm sensu stricto. However, the clinical picture looked very much like lymphadenitis in acute diseased mice. Evaluating various aspects of their Sm isolates, Aldred et ai. (1974) concluded that they are not identical to those derived from mice and rats. Smith's (1941) primary culture grew anaerobically but became facultatively anaerobic after a few passages. Two types of colonies developed, both of bacilli and, one of them showed extreme pleomorphism. There was no indication of spontaneous development of L-forms as described by Klieneberger (1942) . Lack of further phenotypical characters impede a comparison with Sm sensu stricto.
Gerbil There is one report giving some evidence that gerbils might function as carriers of Sm and thus may transmit ratbite fever to humans (Wilkens et al. 1988) .
Nothing is noted about its pathogenicity to gerbils.
Cat Although cat scratches and bites are repeatedly described (mainly in textbooks) as possible vectors of transmission of Sm to man, there is no confirmatory evidence that cats act as carriers and transmitters of Sm. Gascard et a1. (1967) described a patient with septicaemia showing typical accompanying rat-bite fever symptoms after a cat bite. Although Sm could neither be isolated from blood culture nor confirmed by serology, the authors finally diagnosed a septicaemia due to Sm. Dog Das (1986) isolated Sm from the aspirate of an abscess in the left scapula of a dog. Its growth characteristics, growth on non-supplemented brain heart infusion agar, and resistance to an undefined 'majority of antibiotics' is not in accordance with the Sm sensu stricto. Our observations and a survey of the literature [see below) concerning susceptibility to antibiotics showed a broad spectrum of antibiotics to be effective under in vitro conditions. The dog recovered under 'strepto-penicillin' therapy.
Old reports concerning rat-bite fever acquired after dog-bites should be regarded as sceptically as those concerning cat bites and scratches. Study of the original literature shows that the aetiology of ratbite fever is often unclear or can be traced back to Spirillum (minus?), the causative agent of sodoku, the other form of rat-bite fever (Ripley & van Sant 1934) .
Other laboratory animals Nothing is known on the occurrence of 8m sensu stricto in hamsters, rabbits, ferrets and primates. Experimental infections of chickens (Boyer et a1. 1958 , Yamamoto & Clark 1966 , Ghinder et a1. 1982 , rabbits and hamsters (Boyer et al. 1958) with turkey isolates failed. Rabbits inoculated subcutaneously with Smith's (Smith 1941) guineapig isolate developed slowly-growing abscesses at the site of injection. Intratesticular inoculation led to a purulent orchitis. As already mentioned, this isolate should not be regarded as typical Sm.
Domestic animals
There are 4 reports of turkeys becoming diseased after natural infection with Sm IBoyer et a1. 1958 Mohamed et a1. 1969 , Ghlnder et ai. 1982 . The authors described purulent alterations of different joints, tendon sheaths and the bursa sternalis. In some cases the infection could be traced back to feral rats caught in the enclosure environs (Yamamoto & Clark 1966, Mohamed et a1. 1969 ). Attempts to infect lambs and pigs via different routes failed (Mohamed et ai. 1969) . Hopkinson & Lloyd (1981) described several cases of septicaemia in spinifex hopping mice (Notomys alexis) kept at the Perth Zoological Garden (Australia). Rats which broke into the animal cages, were considered the most likely source of infection. From the same continent, there is a report of a koala (Phascolarctos cinereus) that died in the course of pleuritis caused by Sm (Russell & Straube 1979l. Cases of rat-bite fever caused by wild mice (Jenkinson & Jordan 1932 , Reitzel et a1. 1936 and a weasel (Dick & Tunnicliff 1918) were most likely not due to Sm.
Other animals

Inanimate environment
Nothing is known of the occurrence of Sm in the inanimate environment. Under in vitro conditions viability of Sm is poor, so the microorganism has to be stored deepfrozen, lyophilized or be passaged at 3 to 5 day intervals.
Diagnosis of streptobacillary infection
Problems in diagnosing streptobacillosis in humans have been mentioned briefly already. Rumley et a1. (1987) speak of a 'diagnostic dilemma' and summarize the problem as follows: 'Although rat-bite fever is an uncommon disease, we believe that the non-specific clinical manifestations, difficulties with organism identification, and problems with identifying rodent exposure make an accurate diagnosis quite difficult.' Moreover, it has to be pointed out that the recovery of Sm from routinely taken blood culture is impeded by the use of sodium polyanethol sulphonate (liquoid) in blood culture bottles ILambe et al. 1973 However, improvements may be on the way if one takes the increasing number of reports on Sm as indicative of an increasing sensitivity for this pathogen.
Once grown, its typj.cal morphological appearance and growth characteristics on culture make it relatively simple to establish a preliminary diagnosis of Sm followed by biochemical identification in test tubes on serum-supplemented media [commercial test kits fail to identify Sm).
Fatty acid profiles obtained by gas-liquid chromatography (GC) together with characteristic growth in serum broth and the Gram stain reaction can also be used for rapid identification of Sm (Rowbotham 1983) .
The classical test to confirm the diagnosis of streptobacillus is the foot pad injection of Sm performed in mice. Within days a localized septic arthritis develops from which Sm can be isolated in pure culture. Ethical considerations should forbid this painful test, especially as sensitive in vitro identification can be achieved.
There is still a need for an appropriate selective medium for the cultivation of Sm from silent carriers whereas the isolation from purulent or septicaemic processes usually does not cause any problem. The problem of isolating Sm from a mixed flora in carriers, especially from the nasopharynx, is impeded by its slow growth and the risk of being overgrown by Gram-negative bacteria, e.g. Proteus mirabilis (coprophagia) and the nasopharyngeal Gram-positive flora. Elimination of Enterobacteriaceae can easily be achieved by addition of nalidixic acid [1mg/l) to the medium (Wullenweber et a1. 1991) , but methods of suppressing the Gram-positive flora still need to be developed.
Serological methods were used early on the indirect detection of Sm infections. Historically, the first method applied was the demonstration of agglutinating antibodies against Sm. During the Haverhill epidemic, Parker and Hudson (1926) demonstrated anti-Sm-agglutinins in the blood of RBF patients. Brown and Nunemaker (1942) showed the presence of Wullenweber agglutinating antibodies in experimentally infected mice and in human cases of RBF. Van Rooyen (1936) described the agglutination test as a tool for taxonomic studies on Sm strains. Even recent investigations used the agglutination test, Savage (1972) on experimentally infected mice, and RaHin and Freemark (1979) on a case of RBF.
The complement fixation test (CFT) to detect Sm infections was used by Bell and Elmes (1969) and Gay et a1. (1972) for routine monitoring of SPF and conventional laboratory rats and by Savage (1972) on mice suffering from experimental streptobacillary arthritis.
By introducing modern methods into serologic diagnosis of streptobacillary infection, routine testing became more convenient. The indirect immunofluorescence test (IIF) was and is in use in this laboratory for routine testing of breeding and experimental mouse colonies (Wullenweber et a1. 1990 , Wullenweber et a1. 1992 and in rats (Wullenweber &. Nicklas unpublished, see also below). Furthermore, the ELISAtechnique (Koopman et 01. 1991, Boot et a1. in press) has been shown to be applicable to the detection of anti-Sm-antibodies in rat sera.
The use of serological techniques always raises the question of specificity. In adsorption experiments with Sm hyperimmune sera, cells of Bordetella bronchiseptica, Campylobacter fetus, Campylobacter sputorum, Eikenella corrodens, Escherichia coli, Haemophilus sp., Mycoplasma pulmonis and Pasteurella pneumotropica were not able to reduce ELISAactivity. There was only a partial reduction with Acholeplasma laidlawii (Boot et a1. in press). Using the I1F, we observed cross-reactivity between Sm ATCC 49567 and rabbit antisera to A. laidlawii ATCC 23206, A. axanthum H86N, A. oculi ATCC 27350 and A. equifeto1e ATCC 29724, but not to other Acholeplasma species, Mycoplasma pulmonis and M. arthritidis. These are the only available investigations concerning information on cross-reactivity between Sm and other bacterial groups. With respect to routine monitoring by means of the ELISA, it should be pointed out that sera to be tested should derive from rats not older than 16 weeks, otherwise an age-dependent increase of false positive findings can be observed (Boot personal communication). Etscorn and Blodgett (1987) stated that 10 to 100% of otherwise healthy rats harbour Sm as part of their normal nasopharyngeal flora, and further, that approx. 10% of about 14,000 annual bites in US laboratories and in urban areas with poor sanitation result in rat-bite fever. Recent reports clearly give evidence that laboratory animals can still be contaminated with Sm: pneumonia in a guineapig (Kirchner et 01. 1992) , epizootic in C57BL/6 mice (Wullenweber et 01. 1990) , healthy rats (Koopman et 01. 1991) and rats suffering from otitis media (Wullenweber et 01. 1992) . In the latter case, diseased animals came from a German university animal facility, and 19 of 25 rat sera derived from 6 different inbred strains of rats showed high titres of IgG IIF [unpublished), indicating a high degree of contamination of the unit with Sm.
Being startled by these findings, R. Boot (RIVM, Bilthoven, NL), W. Nicklas [DKFZ, Heidelberg, FRG) and I started a serological investigation of European rat colonies. The goal of this interlaboratory co-operation is to evaluate better the incidence of contamination with Sm. Identities of the sera were coded before distribution, and results were exchanged at the end of the testing. Using the ELISA (RB)and the IIF [WN and MW), we found a considerable number of positive rat sera. Results obtained were in good agreement. A limited number of healthy rats were investigated culturally and serologically. Although some of the investigated rats were seropositive in all 3 labs, we failed to isolate Sm, but known difficulties in isolating Sm from healthy animals from a mixed flora, in spite of using a semiselective medium, have to be taken into consideration. This poses some difficulties in interpretation of the findings. Axe the colonies really infected with Sm or did we have false positive results due to some 9 unknown factors like cross-reactions, for example with anaerobionts? Moreover, our information on the epidemiology of streptobacillosis is still rather poor. Boot et 01. (in press) described the failure to detect seroconversion in rats after Ln. infection with the Sm type strain [ATCC 14674) and its reisolation. Wullenweber et 01. (1990 unpublished) observed the same phenomenon after oral infection of non-susceptible inbred strains of mice. So, how can this particular problem be solved?
An infective agent such as Sm, which is difficult to isolate, and serological results which cannot be interpreted properly because of failure to isolate the corresponding agent is, in my opinion, a typical application for the PCR (polymerase chain reaction) technique. In my laboratory, Nicola Hofmann is about to amplify and sequence the 16 SrRNA genes of Sm. One objective is to find Sm specific primer sequences for the PCR which, after solving further technical problems, would enable us to establish an alternative confirmatory test to decide whether a rodent colony is contaminated with Sm.
Rat-bite fever as an occupational risk
The reported incidence of RBF caused by Sm in laboratory personnel is low. Anderson et 01. (1983) documented 13 cases of RBF in the USA between 1958 and 1983. Of these, 5 cases could be traced back to Sm transferred by bites of laboratory rats. Holden and McKay (1964) recorded the first culturally proven Canadian case of RBF due to Sm in a laboratory worker who was bitten by a rat derived from a contaminated colony.
In Norway [Borgen &. Gaustad 1948l, the first documented case of RBF in laboratory personnel occurred in 1946.
In England} a worker at the National Institute of Medical Research at Mill Hill (Gledhill 1967) suffered from RBF, and in Australia} an agricultural scientist developed RBF after being bitten by a laboratory mouse (Gilbert et 01. 1971) . The latter diagnosis was only presumptive as no causative agent could be isolated Ampicillin, azlocillin, aztreonam, cefalozin, cefixime, cefotaxime, Cefoxitin, cefpirome, ceftazidime, c1indamycin, erythromycin a , Fosfomycin, imipenem, meropenem, mezlocillin, mezlocillin/sulbactam, Nitrofurantoin, novobiocin a , ofloxacin, oxacillin, penicillin, Piperacillin, Rifampicin, teicoplanin, tetracycline, vancomycin Amikacin, chloramphenicol, ciprofloxacin, gentamicin The fact that only a few occupational cases are reported does not necessarily represent the real incidence of RBF in laboratory personnel. As Wilkens et 01. (1988) stated '.... Despite this, S. momliformis may be a commoner cause of the triad fever, arthralgia and rash, than is realized, the diagnosis being missed because of the organism's strict growth requirements and the generally low index of suspicion among clinicians'. RaHin and Freemark (1979) evaluated the problem ' .... Although rarely considered as a diagnosis, streptobacillary rat-bite fever continues to merit our consideration, particularly in areas of rural poverty and urban crowding where sanitation is poor and children may come in contact with rats. The true incidence of the disease at present is unknown. One can only wonder if the incidence of a recognizable form of the disease and its potentially severe complications would be appreciably higher were it not for frequent use of penicillins in ambulatory paediatric settings.'
Special attention to streptobacillary RBF should be taken in those facilities where wild rodents are used.
Antibiotic susceptibility and antimicrobial therapy
Penicillin is still regarded as the antibiotic of first choice for the treatment of human RBF. Roughgarden (1965) who reviewed the antimicrobial therapy of RBF, recommended a daily dosage of not less than 400,000 to 600,000 units continued for not less than 7 daysj if no response occurs within 2 days, the dosage should be raised to 1,200.000 units daily. In the case of endocarditis, 12 to 15 million units daily should be given either intravenously or intramuscularly for 3 to 4 weeks. Further information on treatment of S. moniliformis endocarditis can be obtained from 2 recent review articles (Rey et al. 1987 , Rupp 1992 .
Other antibiotics used for the treatment of streptobacillary RBF in humans are ampicillin (Mandel 1985 , Kunnert et al. 1985 , streptomycin (McGill et al. 1966) , tetracycline (Holden & McKay 1964), chloramphenicol (Hamburger & Knowles 1953) , gentamicin (Rumley et al. 1987j, cefuroxime (Clausen 1987 , vancomycin (Fordham et 01. 1992) and erythromycin (Konstantopoulos et al. 1992) . Usually antibiotics were given in combinations.
In vitro testing of antibiotic susceptibility with different techniques e.g. agar incorporation method of MIC determination [Edwards & Finch 1986) and disk diffusion technique (Wullenweber et al. 1990 , Rygg &. Bruun 1992 revealed similar results, all showing a broad spectrum of antibiotic sensitivity of the Sm isolates tested.
A comparison of the antibiotic susceptibility of 13 different Sm isolates of human, murine and avian origin using break point microtitre plates (Radiometer, Copenhagen) is given in There appears to be a lack of information on antibiotic treatment of diseased laboratory animals. On the occasion of a Sm epizootic amongst mice which occurred in our institute in 1988, we tried to treat the breeding nuclei with ampicillin in drinking water. Ampicillin was chosen because of its good penetration into the joint cavities. To prevent survival of penicillin-resistant L-forms, tetracycline was given in succession. The efficiency of the antibiotic treatment was controlled in naturally infected C57BL/6 mice kept in an isolator (Wullenweber et al. 1990 ). Clinical signs decreased dramatically under therapy within 24 h. Most of the animals recovered completely. However, after finishing therapy, some of the mice relapsed, became emaciated and died with septicaemia. So the field trial was stopped, and the breeding unit abandoned (Wullenweber et al. 1990 ).
Geographical aspects
Quantitatively, most of the references concerning Sm in humans and animals originate from the US literature, and are already summarized in a couple of papers (see e.g. Brown & Nunemaker 1942, Roughgarden 1965 , Anderson et al. 1983 . Table 3 , therefore refers exclusively to non-US cases.
Concerning the American continent, occurrence of Sm has been described in Brazil, Canada, Mexico and Paraguay. With respect to Europe, most reports come from the United Kingdom (13) and France (81, but its occurrence is also documented for Norway, Finland, Germany, Spain, Italy, Greece, Poland, Denmark and The Netherlands. Australian authors have contributed three reports. The only paper from Asia (India) describes the isolation of Sm from an abscess of a dog (Das 1986 ). As mentioned before, the nutritional requirements and antibiotic sensitivity of this isolate is not typical for Sm sensu stricto. There is no report from Africa. Lack of reports from third world countries probably understates the real incidence of Sm because it is known that the distribution of streptobacillosis is correlated with poor sanitation, rural areas Wullenweber and agricultural occupations (Clausen 1987 , Gilbert et al. 1971 ).
Final remarks
My principal intention in writing this article was to promote interest in the scientific community in our field of research on this, in many respects, remarkable bacterium. Although I must not overestimate problems in which Streptobacillus moniliformis might be involved, I fear that, after studying programmes of recent congresses on laboratory animals and many discussions with colleagues, microbiological study of the animals we are working with risk being pushed aside by other topics, e.g. animal welfare aspects, ethics etc. However, animal welfare includes a duty to keep laboratory animals free from pathogenic microorganisms. By this, avoidable stress and pain during maintenance and experimentation can be reduced. Keeping laboratory animals free from zoonotic pathogens also reduces occupational hazard. Moreover, for bacteriologists, Sm is a fascinating microorganism which poses a lot of questions to be answered in the future.
Addendum
In the meantime, 16 S rRNA analysis could be finished. There are 2 Sm subspecies which show relationship to Sebaldella termitidis and some Fusobacterium spp. (Hofmann & Wullenweber, in preparation) .
